Corrigendum to "Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study" [Endocrine Practice 30 (2024) 424-430].
Endocr Pract
; 30(9): 898, 2024 Sep.
Article
en En
| MEDLINE
| ID: mdl-39023469
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Año:
2024
Tipo del documento:
Article